TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2116324
log Bayes Factor = <0.0001
Chromosome 4   position 90,190,815  (GRCh37) Explore rs2116324 on Ensembl!
Variant rs2116324 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
D86.9 Sarcoidosis, unspecified
0.028 0.972 0.000
D86 Sarcoidosis
0.025 0.975 0.000
D86.1 Sarcoidosis of lymph nodes
0.023 0.976 0.000
D86.8 Sarcoidosis of other and combined sites
0.022 0.978 0.000
D86.3 Sarcoidosis of skin
0.018 0.981 0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
0.018 0.981 0.000
D86.0 Sarcoidosis of lung
0.018 0.982 0.000
D80-D89 Certain disorders involving the immune mechanism
0.015 0.985 0.000
Y57 Other and unspecified drugs and medicaments
0.014 0.986 0.000
Y57.9 Drug or medicament, unspecified
0.014 0.986 0.000
T40.2 Other opioids
0.014 0.986 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.013 0.987 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.013 0.987 0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.012 0.988 0.000
D80 Immunodeficiency with predominantly antibody defects
0.012 0.988 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.012 0.988 0.000
Y40 Systemic antibiotics
0.012 0.988 0.000
Y57.5 X-ray contrast media
0.012 0.988 0.000
T40.6 Other and unspecified narcotics
0.012 0.988 0.000
M50.3 Other cervical disk degeneration
0.000 0.988 0.012
D84 Other immunodeficiencies
0.012 0.988 0.000
Y43 Primarily systemic agents
0.012 0.988 0.000
D83 Common variable immunodeficiency
0.012 0.988 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.012 0.988 0.000
D82 Immunodeficiency associated with other major defects
0.011 0.989 0.000
D81 Combined immunodeficiencies
0.011 0.989 0.000
G83.4 Cauda equina syndrome
0.011 0.989 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.011 0.989 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.011 0.989 0.000
Y54.8 Agents affecting uric acid metabolism
0.011 0.989 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.011 0.989 0.000
Y57.8 Other drugs and medicaments
0.011 0.989 0.000
D89.0 Polyclonal hypergammaglobulinaemia
0.010 0.989 0.000
M50.0 Cervical disk disorder with myelopathy
0.000 0.989 0.011
Y41.5 Antiviral drugs
0.010 0.989 0.000
T40.4 Other synthetic narcotics
0.010 0.990 0.000
Y43.3 Other antineoplastic drugs
0.010 0.990 0.000
Y57.6 Other diagnostic agents
0.010 0.990 0.000
Y40.0 Penicillins
0.010 0.990 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.010 0.990 0.000
Y57.7 Vitamins, not elsewhere classified
0.010 0.990 0.000
Y57.4 Pharmaceutical excipients
0.010 0.990 0.000
Y57.3 Alcohol deterrents
0.010 0.990 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.010 0.990 0.000
Y57.1 Lipotropic drugs
0.010 0.990 0.000
Y57.0 Appetite depressants [anorectics]
0.010 0.990 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.010 0.990 0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
0.010 0.990 0.000
Y40.6 Rifamycins
0.010 0.990 0.000
Y48 Anaesthetics and therapeutic gases
0.010 0.990 0.000
M50 Cervical disk disorders
0.000 0.990 0.010
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses
0.010 0.990 0.000
Y40.8 Other systemic antibiotics
0.010 0.990 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.010 0.990 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.010 0.990 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.010 0.990 0.000
Y59 Other and unspecified vaccines and biological substances
0.010 0.990 0.000
Y58 Bacterial vaccines
0.010 0.990 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.010 0.990 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.010 0.990 0.000
D89.1 Cryoglobulinaemia
0.010 0.990 0.000
N94.8 Other specified conditions associated with female genital organs and menstrual cycle
0.000 0.990 0.010
Y46.6 Other and unspecified antiepileptics
0.009 0.990 0.000
Y43.4 Immunosuppressive agents
0.009 0.991 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.009 0.991 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.009 0.991 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.009 0.991 0.000
T40.8 Lysergide [LSD]
0.009 0.991 0.000
T40.7 Cannabis (derivatives)
0.009 0.991 0.000
T40.5 Cocaine
0.009 0.991 0.000
T40.3 Methadone
0.009 0.991 0.000
T40.1 Heroin
0.009 0.991 0.000
T40.0 Opium
0.009 0.991 0.000
D89.9 Disorder involving the immune mechanism, unspecified
0.009 0.991 0.000
D84.9 Immunodeficiency, unspecified
0.009 0.991 0.000
Y47.1 Benzodiazepines
0.009 0.991 0.000
D83.9 Common variable immunodeficiency, unspecified
0.009 0.991 0.000
M23.22 Derangement of meniscus due to old tear or injury (Posterior cruciate ligament or Posterior horn of medial meniscus)
0.009 0.991 0.000
Y43.0 Antiallergic and antiemetic drugs
0.009 0.991 0.000
D89.3 Immune reconstitution syndrome
0.009 0.991 0.000
Y48.2 Other and unspecified general anaesthetics
0.009 0.991 0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified
0.009 0.991 0.000
D80.8 Other immunodeficiencies with predominantly antibody defects
0.009 0.991 0.000
D80.7 Transient hypogammaglobulinaemia of infancy
0.009 0.991 0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
0.009 0.991 0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
0.009 0.991 0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]
0.009 0.991 0.000
D80.0 Hereditary hypogammaglobulinaemia
0.009 0.991 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.009 0.991 0.000
Y41.4 Anthelminthics
0.009 0.991 0.000
Y41.3 Other antiprotozoal drugs
0.009 0.991 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.009 0.991 0.000
Y41.1 Antimycobacterial drugs
0.009 0.991 0.000
Y41.0 Sulphonamides
0.009 0.991 0.000
Y40.7 Antifungal antibiotics, systemically used
0.009 0.991 0.000
Y40.5 Aminoglycosides
0.009 0.991 0.000
Y40.4 Tetracyclines
0.009 0.991 0.000
Y40.2 Chloramphenicol group
0.009 0.991 0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]
0.009 0.991 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.009 0.991 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.009 0.991 0.000
D84.8 Other specified immunodeficiencies
0.009 0.991 0.000
D84.1 Defects in the complement system
0.009 0.991 0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect
0.009 0.991 0.000
Y43.9 Primarily systemic agent, unspecified
0.009 0.991 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.009 0.991 0.000
Y43.6 Enzymes, not elsewhere classified
0.009 0.991 0.000
Y43.5 Acidifying and alkalising agents
0.009 0.991 0.000
Y43.2 Antineoplastic natural products
0.009 0.991 0.000
D83.8 Other common variable immunodeficiencies
0.008 0.991 0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells
0.008 0.991 0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
0.008 0.991 0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
0.008 0.991 0.000
C71.9 Brain, unspecified
0.000 0.991 0.009
Y54.9 Mineral salts, not elsewhere classified
0.008 0.991 0.000
Y54.7 Agents affecting calcification
0.008 0.991 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.008 0.991 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.008 0.991 0.000
Y54.0 Mineralocorticoids
0.008 0.991 0.000
D80.1 Nonfamilial hypogammaglobulinaemia
0.008 0.991 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.008 0.991 0.000
Y40.9 Systemic antibiotic, unspecified
0.008 0.991 0.000
Y44 Agents primarily affecting blood constituents
0.008 0.991 0.000
Y54.5 Other diuretics
0.008 0.992 0.000
D81.9 Combined immunodeficiency, unspecified
0.008 0.992 0.000
D81.8 Other combined immunodeficiencies
0.008 0.992 0.000
D81.7 Major histocompatibility complex class II deficiency
0.008 0.992 0.000
D81.6 Major histocompatibility complex class I deficiency
0.008 0.992 0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency
0.008 0.992 0.000
D81.4 Nezelof's syndrome
0.008 0.992 0.000
D81.3 Adenosine deaminase [ADA] deficiency
0.008 0.992 0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
0.008 0.992 0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
0.008 0.992 0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis
0.008 0.992 0.000
D82.9 Immunodeficiency associated with major defect, unspecified
0.008 0.992 0.000
D82.8 Immunodeficiency associated with other specified major defects
0.008 0.992 0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome
0.008 0.992 0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus
0.008 0.992 0.000
D82.2 Immunodeficiency with short-limbed stature
0.008 0.992 0.000
D82.1 Di George's syndrome
0.008 0.992 0.000
D82.0 Wiskott-Aldrich syndrome
0.008 0.992 0.000
Y46.4 Iminostilbenes
0.008 0.992 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.008 0.992 0.000
Y53.7 Emetics
0.008 0.992 0.000
Y53.6 Antidiarrhoeal drugs
0.008 0.992 0.000
Y53.5 Digestants
0.008 0.992 0.000
Y53.4 Other laxatives
0.008 0.992 0.000
Y53.3 Saline and osmotic laxatives
0.008 0.992 0.000
Y53.2 Stimulant laxatives
0.008 0.992 0.000
Y53.0 Histamine H2-receptor antagonists
0.008 0.992 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.008 0.992 0.000
Y46.8 Antispasticity drugs
0.008 0.992 0.000
Y46.7 Anti-Parkinsonism drugs
0.008 0.992 0.000
Y46.5 Valproic acid
0.008 0.992 0.000
Y46.3 Deoxybarbiturates
0.008 0.992 0.000
Y46.1 Oxazolidinediones
0.008 0.992 0.000
Y46.0 Succinimides
0.008 0.992 0.000
M50.9 Cervical disk disorder, unspecified
0.000 0.992 0.008
N94.9 Unspecified condition associated with female genital organs and menstrual cycle
0.000 0.992 0.008
T39.0 Salicylates
0.008 0.992 0.000
Y46.2 Hydantoin derivatives
0.008 0.992 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.008 0.992 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.008 0.992 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.008 0.992 0.000
Y47.4 Bromine compounds
0.008 0.992 0.000
Y47.3 Paraldehyde
0.008 0.992 0.000
Y47.2 Chloral derivatives
0.008 0.992 0.000
Y47.0 Barbiturates, not elsewhere classified
0.008 0.992 0.000
M50.1 Cervical disk disorder with radiculopathy
0.000 0.992 0.008
Y54.3 Benzothiadiazine derivatives
0.008 0.992 0.000
Y43.1 Antineoplastic antimetabolites
0.008 0.992 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.008 0.992 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.008 0.992 0.000
Y54.4 Loop [high-ceiling] diuretics
0.008 0.992 0.000
Y52 Agents primarily affecting the cardiovascular system
0.008 0.992 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.008 0.992 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.008 0.992 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.008 0.992 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.008 0.992 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.008 0.992 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.008 0.992 0.000
Y51.0 Anticholinesterase agents
0.008 0.992 0.000
N94 Pain and other conditions associated with female genital organs and menstrual cycle
0.000 0.993 0.007
Y48.5 Therapeutic gases
0.007 0.993 0.000
Y48.1 Parenteral anaesthetics
0.007 0.993 0.000
Y48.0 Inhaled anaesthetics
0.007 0.993 0.000
Y49.9 Psychotropic drug, unspecified
0.007 0.993 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.007 0.993 0.000
Y49.7 Psychostimulants with abuse potential
0.007 0.993 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.007 0.993 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.007 0.993 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.007 0.993 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.007 0.993 0.000
Y56.9 Topical agent, unspecified
0.007 0.993 0.000
Y56.8 Other topical agents
0.007 0.993 0.000
Y56.7 Dental drugs, topically applied
0.007 0.993 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.007 0.993 0.000
Y56.5 Ophthalmological drugs and preparations
0.007 0.993 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.007 0.993 0.000
Y56.3 Emollients, demulcents and protectants
0.007 0.993 0.000
Y56.2 Local astringents and local detergents
0.007 0.993 0.000
Y56.1 Antipruritics
0.007 0.993 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.007 0.993 0.000
Y50.9 Central nervous system stimulant, unspecified
0.007 0.993 0.000
Y50.8 Other central nervous system stimulants
0.007 0.993 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.007 0.993 0.000
Y50.1 Opioid receptor antagonists
0.007 0.993 0.000
Y50.0 Analeptics
0.007 0.993 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.007 0.993 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.007 0.993 0.000
Y55.5 Anticommon cold drugs
0.007 0.993 0.000
Y55.4 Expectorants
0.007 0.993 0.000
Y55.3 Antitussives
0.007 0.993 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.007 0.993 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.007 0.993 0.000
Y55.0 Oxytocic drugs
0.007 0.993 0.000
Y58.9 Other and unspecified bacterial vaccines
0.007 0.993 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.007 0.993 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.007 0.993 0.000
Y58.5 Diphtheria vaccine
0.007 0.993 0.000
Y58.4 Tetanus vaccine
0.007 0.993 0.000
Y58.3 Plague vaccine
0.007 0.993 0.000
Y58.2 Cholera vaccine
0.007 0.993 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.007 0.993 0.000
Y58.0 BCG vaccine
0.007 0.993 0.000
Y59.9 Vaccine or biological substance, unspecified
0.007 0.993 0.000
Y59.8 Other specified vaccines and biological substances
0.007 0.993 0.000
Y59.3 Immunoglobulin
0.007 0.993 0.000
Y59.2 Protozoal vaccines
0.007 0.993 0.000
Y59.1 Rickettsial vaccines
0.007 0.993 0.000
Y59.0 Viral vaccines
0.007 0.993 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.007 0.993 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.007 0.993 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.007 0.993 0.000
Y49.5 Other antipsychotics and neuroleptics
0.007 0.993 0.000
Y49.2 Other and unspecified antidepressants
0.007 0.993 0.000
T39.1 4-Aminophenol derivatives
0.007 0.993 0.000
Y48.4 Anaesthetic, unspecified
0.006 0.993 0.000
C71 Malignant neoplasm of brain
0.000 0.993 0.007
Y40.3 Macrolides
0.006 0.993 0.000
M50.8 Other cervical disk disorders
0.000 0.993 0.006
T45.0 Antiallergic and antiemetic drugs
0.006 0.993 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.006 0.993 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.006 0.993 0.000
N94.3 Premenstrual tension syndrome
0.000 0.993 0.006
Y52.1 Calcium-channel blockers
0.006 0.994 0.000
C71.2 Temporal lobe
0.000 0.994 0.006
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.006 0.994 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.006 0.994 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.006 0.994 0.000
Y44.7 Plasma substitutes
0.006 0.994 0.000
Y44.6 Natural blood and blood products
0.006 0.994 0.000
Y44.5 Thrombolytic drugs
0.006 0.994 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.006 0.994 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.006 0.994 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.006 0.994 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.006 0.994 0.000
N94.5 Secondary dysmenorrhoea
0.000 0.994 0.006
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.006 0.994 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.006 0.994 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.006 0.994 0.000
M50.2 Other cervical disk displacement
0.000 0.994 0.006
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.006 0.994 0.000
T39.4 Antirheumatics, not elsewhere classified
0.006 0.994 0.000
T39.2 Pyrazolone derivatives
0.006 0.994 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.006 0.994 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.006 0.994 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.006 0.994 0.000
T46.1 Calcium-channel blockers
0.006 0.994 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.006 0.994 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.006 0.994 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.006 0.994 0.000
Y52.7 Peripheral vasodilators
0.006 0.994 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.006 0.994 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.006 0.994 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.006 0.994 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.006 0.994 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.006 0.994 0.000
Y48.3 Local anaesthetics
0.005 0.994 0.000
N94.2 Vaginismus
0.000 0.994 0.005
T36 Poisoning by systemic antibiotics
0.005 0.994 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.005 0.994 0.000
N94.0 Mittelschmerz
0.000 0.994 0.005
Y45.2 Propionic acid derivatives
0.005 0.994 0.000
C71.1 Frontal lobe
0.000 0.995 0.005
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.005 0.995 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.005 0.995 0.000
T46.7 Peripheral vasodilators
0.005 0.995 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.005 0.995 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.005 0.995 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.005 0.995 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.005 0.995 0.000
T45.8 Other primarily systemic and haematological agents
0.005 0.995 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.005 0.995 0.000
T45.6 Fibrinolysis-affecting drugs
0.005 0.995 0.000
T45.4 Iron and its compounds
0.005 0.995 0.000
T45.3 Enzymes, not elsewhere classified
0.005 0.995 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.005 0.995 0.000
T45.5 Anticoagulants
0.005 0.995 0.000
T45.2 Vitamins, not elsewhere classified
0.005 0.995 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.005 0.995 0.000
Y42.7 Androgens and anabolic congeners
0.005 0.995 0.000
C71.3 Parietal lobe
0.000 0.995 0.005
T37.8 Other specified systemic anti-infectives and antiparasitics
0.005 0.995 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.005 0.995 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.005 0.995 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.005 0.995 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.005 0.995 0.000
T44.0 Anticholinesterase agents
0.005 0.995 0.000
Y44.2 Anticoagulants
0.005 0.995 0.000
C71.7 Brain stem
0.000 0.995 0.005
C71.6 Cerebellum
0.000 0.995 0.005
C71.5 Cerebral ventricle
0.000 0.995 0.005
N94.4 Primary dysmenorrhoea
0.000 0.995 0.005
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.005 0.995 0.000
C71.0 Cerebrum, except lobes and ventricles
0.000 0.995 0.005
T45.1 Antineoplastic and immunosuppressive drugs
0.005 0.995 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.005 0.995 0.000
T37.5 Antiviral drugs
0.005 0.995 0.000
T37.4 Anthelminthics
0.005 0.995 0.000
T37.3 Other antiprotozoal drugs
0.005 0.995 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.005 0.995 0.000
T37.1 Antimycobacterial drugs
0.005 0.995 0.000
T37.0 Sulphonamides
0.005 0.995 0.000
T43.6 Psychostimulants with abuse potential
0.005 0.995 0.000
T43.2 Other and unspecified antidepressants
0.005 0.995 0.000
Y45.4 Antirheumatics
0.005 0.995 0.000
C71.8 Overlapping lesion of brain
0.000 0.995 0.005
C71.4 Occipital lobe
0.000 0.995 0.005
T38.1 Thyroid hormones and substitutes
0.005 0.995 0.000
T41.5 Therapeutic gases
0.004 0.995 0.000
T41.4 Anaesthetic, unspecified
0.004 0.995 0.000
T41.3 Local anaesthetics
0.004 0.995 0.000
T41.2 Other and unspecified general anaesthetics
0.004 0.995 0.000
T41.1 Intravenous anaesthetics
0.004 0.995 0.000
T41.0 Inhaled anaesthetics
0.004 0.995 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.004 0.995 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.004 0.995 0.000
T48.5 Anti-common-cold drugs
0.004 0.995 0.000
T48.4 Expectorants
0.004 0.995 0.000
T48.3 Antitussives
0.004 0.995 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.004 0.995 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.004 0.995 0.000
T48.0 Oxytocic drugs
0.004 0.995 0.000
T49.9 Topical agent, unspecified
0.004 0.995 0.000
T49.8 Other topical agents
0.004 0.995 0.000
T49.7 Dental drugs, topically applied
0.004 0.995 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.004 0.995 0.000
T49.5 Ophthalmological drugs and preparations
0.004 0.995 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.004 0.995 0.000
T49.3 Emollients, demulcents and protectants
0.004 0.995 0.000
T49.2 Local astringents and local detergents
0.004 0.995 0.000
T49.1 Antipruritics
0.004 0.995 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.004 0.995 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.004 0.995 0.000
Z73.9 Problem related to life-management difficulty, unspecified
0.005 0.995 0.000
Q61.2 Polycystic kidney, adult type
0.005 0.995 0.000
Y42.9 Other and unspecified hormone antagonists
0.004 0.995 0.000
Y42.4 Oral contraceptives
0.004 0.995 0.000
Y42.2 Antithyroid drugs
0.004 0.995 0.000
Y42.1 Thyroid hormones and substitutes
0.004 0.995 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.004 0.995 0.000
D89.2 Hypergammaglobulinaemia, unspecified
0.004 0.995 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.004 0.995 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.004 0.995 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.004 0.995 0.000
N94.1 Dyspareunia
0.000 0.995 0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.004 0.996 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.004 0.996 0.000
T47.7 Emetics
0.004 0.996 0.000
T47.6 Antidiarrhoeal drugs
0.004 0.996 0.000
T47.5 Digestants
0.004 0.996 0.000
T47.4 Other laxatives
0.004 0.996 0.000
T47.3 Saline and osmotic laxatives
0.004 0.996 0.000
T47.2 Stimulant laxatives
0.004 0.996 0.000
T47.0 Histamine H(2)-receptor antagonists
0.004 0.996 0.000
Y45.1 Salicylates
0.004 0.996 0.000
Q61 Cystic kidney disease
0.004 0.996 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.004 0.996 0.000
T38.9 Other and unspecified hormone antagonists
0.004 0.996 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.004 0.996 0.000
T38.7 Androgens and anabolic congeners
0.004 0.996 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.004 0.996 0.000
T38.5 Other oestrogens and progestogens
0.004 0.996 0.000
T38.4 Oral contraceptives
0.004 0.996 0.000
T38.2 Antithyroid drugs
0.004 0.996 0.000
T38.0 Glucocorticoids and synthetic analogues
0.004 0.996 0.000
T43.9 Psychotropic drug, unspecified
0.004 0.996 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.004 0.996 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.004 0.996 0.000
Y45.8 Other analgesics and antipyretics
0.004 0.996 0.000
N94.6 Dysmenorrhoea, unspecified
0.000 0.996 0.004
Q61.3 Polycystic kidney, unspecified
0.004 0.996 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.004 0.996 0.000
T36.9 Systemic antibiotic, unspecified
0.004 0.996 0.000
T36.8 Other systemic antibiotics
0.004 0.996 0.000
T36.7 Antifungal antibiotics, systemically used
0.004 0.996 0.000
T36.6 Rifamycins
0.004 0.996 0.000
T36.5 Aminoglycosides
0.004 0.996 0.000
T36.4 Tetracyclines
0.004 0.996 0.000
T36.3 Macrolides
0.004 0.996 0.000
T36.2 Chloramphenicol group
0.004 0.996 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.004 0.996 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.004 0.996 0.000
Y45.5 4-Aminophenol derivatives
0.004 0.996 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.004 0.996 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.004 0.996 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.004 0.996 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.004 0.996 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.996 0.004
Q61.9 Cystic kidney disease, unspecified
0.004 0.996 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.004 0.996 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.004 0.996 0.000
T36.0 Penicillins
0.003 0.996 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.003 0.996 0.000
Y45.0 Opioids and related analgesics
0.004 0.996 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.004 0.996 0.000
M23.21 Derangement of meniscus due to old tear or injury (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.004 0.996 0.000
T50.8 Diagnostic agents
0.003 0.996 0.000
T50.7 Analeptics and opioid receptor antagonists
0.003 0.996 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.003 0.996 0.000
T50.5 Appetite depressants
0.003 0.996 0.000
T50.4 Drugs affecting uric acid metabolism
0.003 0.996 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.003 0.996 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.003 0.996 0.000
T50.1 Loop [high-ceiling] diuretics
0.003 0.996 0.000
T50.0 Mineralocorticoids and their antagonists
0.003 0.996 0.000
Q61.8 Other cystic kidney diseases
0.003 0.997 0.000
Q61.4 Renal dysplasia
0.003 0.997 0.000
Q61.1 Polycystic kidney, infantile type
0.003 0.997 0.000
Q60-Q64 Congenital malformations of the urinary system
0.003 0.997 0.000
Q61.5 Medullary cystic kidney
0.003 0.997 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.003 0.997 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.003 0.997 0.000
Q63 Other congenital malformations of kidney
0.003 0.997 0.000
I21.0 Acute transmural myocardial infarction of anterior wall
0.000 0.997 0.003
N03.9 Unspecified
0.000 0.997 0.003
T42.0 Hydantoin derivatives
0.003 0.997 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.003 0.997 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.003 0.997 0.000
T42.3 Barbiturates
0.003 0.997 0.000
T42.2 Succinimides and oxazolidinediones
0.003 0.997 0.000
O47.1 False labour at or after 37 completed weeks of gestation
0.000 0.997 0.003
Q63.2 Ectopic kidney
0.003 0.997 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.003 0.997 0.000
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
0.000 0.997 0.003
Q63.1 Lobulated, fused and horseshoe kidney
0.003 0.997 0.000
Q61.0 Congenital single renal cyst
0.003 0.997 0.000
T42.1 Iminostilbenes
0.003 0.997 0.000
Q60 Renal agenesis and other reduction defects of kidney
0.003 0.997 0.000
O47.9 False labour, unspecified
0.000 0.997 0.003
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter
0.003 0.997 0.000
Q63.0 Accessory kidney
0.003 0.997 0.000
T42.4 Benzodiazepines
0.003 0.997 0.000
Q63.9 Congenital malformation of kidney, unspecified
0.003 0.997 0.000
Q63.8 Other specified congenital malformations of kidney
0.003 0.997 0.000
Q63.3 Hyperplastic and giant kidney
0.003 0.997 0.000
M23.29 Derangement of meniscus due to old tear or injury (Unspecified ligament or Unspecified meniscus)
0.003 0.997 0.000
J90 Pleural effusion, not elsewhere classified
0.000 0.997 0.003
Q64 Other congenital malformations of urinary system
0.002 0.997 0.000
G83 Other paralytic syndromes
0.002 0.997 0.000
O47 False labour
0.000 0.997 0.003
Y42.5 Other oestrogens and progestogens
0.002 0.997 0.000
M23.2 Derangement of meniscus due to old tear or injury
0.002 0.998 0.000
O80.0 Spontaneous vertex delivery
0.000 0.998 0.002
Q60.0 Renal agenesis, unilateral
0.002 0.998 0.000
N97.9 Female infertility, unspecified
0.002 0.998 0.000
Q60.2 Renal agenesis, unspecified
0.002 0.998 0.000
Q60.6 Potter's syndrome
0.002 0.998 0.000
Q60.5 Renal hypoplasia, unspecified
0.002 0.998 0.000
Q60.4 Renal hypoplasia, bilateral
0.002 0.998 0.000
Q60.3 Renal hypoplasia, unilateral
0.002 0.998 0.000
Q60.1 Renal agenesis, bilateral
0.002 0.998 0.000
O47.0 False labour before 37 completed weeks of gestation
0.000 0.998 0.002
Q62.8 Other congenital malformations of ureter
0.002 0.998 0.000
Q62.7 Congenital vesico-uretero-renal reflux
0.002 0.998 0.000
Q62.6 Malposition of ureter
0.002 0.998 0.000
Q62.5 Duplication of ureter
0.002 0.998 0.000
Q62.4 Agenesis of ureter
0.002 0.998 0.000
Q62.3 Other obstructive defects of renal pelvis and ureter
0.002 0.998 0.000
Q62.2 Congenital megaloureter
0.002 0.998 0.000
Q62.1 Atresia and stenosis of ureter
0.002 0.998 0.000
Q62.0 Congenital hydronephrosis
0.002 0.998 0.000
S72.10 Pertrochanteric fracture (closed)
0.000 0.998 0.002
Q44.6 Cystic disease of liver
0.002 0.998 0.000
E80.4 Gilbert's syndrome
0.002 0.998 0.000
F60.9 Personality disorder, unspecified
0.002 0.998 0.000
K65.9 Peritonitis, unspecified
0.002 0.998 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.000 0.998 0.002
Q64.9 Congenital malformation of urinary system, unspecified
0.002 0.998 0.000
Q64.8 Other specified congenital malformations of urinary system
0.002 0.998 0.000
Q64.7 Other congenital malformations of bladder and urethra
0.002 0.998 0.000
Q64.6 Congenital diverticulum of bladder
0.002 0.998 0.000
Q64.5 Congenital absence of bladder and urethra
0.002 0.998 0.000
Q64.4 Malformation of urachus
0.002 0.998 0.000
Q64.2 Congenital posterior urethral valves
0.002 0.998 0.000
Q64.1 Exstrophy of urinary bladder
0.002 0.998 0.000
Q64.0 Epispadias
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.